Biosimilars makers in Canada to launch patient support program

Generics and Biosimilars Initiative (GaBI) |

Biosimilars Canada, an association representing Canada’s biosimilar makers, announced on 22 November 2018 that it had chosen pharmaceutical service provider Innomar Strategies to be the preferred provider for the association’s Patient Support Program (PSP) platform.